Literature DB >> 35728948

Comment: Humoral and T-cell Immunities to SARS-CoV-2 Vaccines: Safety, Efficacy, and Challenges in Autoimmune Neurology.

Marinos C Dalakas1, Josep Dalmau1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35728948      PMCID: PMC9219497          DOI: 10.1212/NXI.0000000000200010

Source DB:  PubMed          Journal:  Neurol Neuroimmunol Neuroinflamm        ISSN: 2332-7812


× No keyword cloud information.
  14 in total

1.  SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.

Authors:  Nina Le Bert; Anthony T Tan; Kamini Kunasegaran; Christine Y L Tham; Morteza Hafezi; Adeline Chia; Melissa Hui Yen Chng; Meiyin Lin; Nicole Tan; Martin Linster; Wan Ni Chia; Mark I-Cheng Chen; Lin-Fa Wang; Eng Eong Ooi; Shirin Kalimuddin; Paul Anantharajah Tambyah; Jenny Guek-Hong Low; Yee-Joo Tan; Antonio Bertoletti
Journal:  Nature       Date:  2020-07-15       Impact factor: 49.962

2.  Long-lasting treatment effect of rituximab in MuSK myasthenia.

Authors:  J Díaz-Manera; E Martínez-Hernández; L Querol; R Klooster; R Rojas-García; X Suárez-Calvet; J L Muñoz-Blanco; C Mazia; K R Straasheijm; E Gallardo; C Juárez; J J Verschuuren; I Illa
Journal:  Neurology       Date:  2012-01-04       Impact factor: 9.910

3.  Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies.

Authors:  C Paradas; J Llauger; J Diaz-Manera; R Rojas-García; N De Luna; C Iturriaga; C Márquez; M Usón; K Hankiewicz; E Gallardo; I Illa
Journal:  Neurology       Date:  2010-06-23       Impact factor: 9.910

4.  Clinical and therapeutic features of myasthenia gravis in adults based on age at onset.

Authors:  Elena Cortés-Vicente; Rodrigo Álvarez-Velasco; Sonia Segovia; Carmen Paradas; Carlos Casasnovas; Antonio Guerrero-Sola; Julio Pardo; Alba Ramos-Fransi; Teresa Sevilla; Adolfo López de Munain; Maria Teresa Gómez; Ivonne Jericó; Gerardo Gutiérrez-Gutiérrez; Ana Lara Pelayo-Negro; María Asunción Martín; María Dolores Mendoza; Germán Morís; Ricard Rojas-Garcia; Jordi Díaz-Manera; Luis Querol; Eduard Gallardo; Beatriz Vélez; María Antonia Albertí; Lucía Galán; Tania García-Sobrino; Alicia Martínez-Piñeiro; Ana Lozano-Veintimilla; Roberto Fernández-Torrón; Ángel Cano-Abascal; Isabel Illa
Journal:  Neurology       Date:  2020-02-18       Impact factor: 9.910

5.  Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.

Authors:  Luis Querol; Gisela Nogales-Gadea; Ricardo Rojas-Garcia; Jordi Diaz-Manera; Julio Pardo; Angel Ortega-Moreno; Maria Jose Sedano; Eduard Gallardo; Jose Berciano; Rafael Blesa; Josep Dalmau; Isabel Illa
Journal:  Neurology       Date:  2014-02-12       Impact factor: 9.910

6.  A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.

Authors:  M C Dalakas; I Illa; J M Dambrosia; S A Soueidan; D P Stein; C Otero; S T Dinsmore; S McCrosky
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

7.  Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy.

Authors:  J Liu; M Aoki; I Illa; C Wu; M Fardeau; C Angelini; C Serrano; J A Urtizberea; F Hentati; M B Hamida; S Bohlega; E J Culper; A A Amato; K Bossie; J Oeltjen; K Bejaoui; D McKenna-Yasek; B A Hosler; E Schurr; K Arahata; P J de Jong; R H Brown
Journal:  Nat Genet       Date:  1998-09       Impact factor: 38.330

8.  Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies.

Authors:  Carla Tortorella; Alessandra Aiello; Claudio Gasperini; Chiara Agrati; Concetta Castilletti; Serena Ruggieri; Silvia Meschi; Giulia Matusali; Francesca Colavita; Chiara Farroni; Gilda Cuzzi; Eleonora Cimini; Eleonora Tartaglia; Valentina Vanini; Luca Prosperini; Shalom Haggiag; Simona Galgani; Maria Esmeralda Quartuccio; Andrea Salmi; Federica Repele; Anna Maria Gerarda Altera; Flavia Cristofanelli; Alessandra D'Abramo; Nazario Bevilacqua; Angela Corpolongo; Vincenzo Puro; Francesco Vaia; Maria Rosaria Capobianchi; Giuseppe Ippolito; Emanuele Nicastri; Delia Goletti
Journal:  Neurology       Date:  2021-11-22       Impact factor: 11.800

9.  Immune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia Gravis.

Authors:  David Reyes-Leiva; Joaquín López-Contreras; Esther Moga; Francesc Pla-Juncà; Elionor Lynton-Pons; Ricardo Rojas-Garcia; Janina Turon-Sans; Luis Querol; Montse Olive; Rodrigo Álvarez-Velasco; Marta Caballero-Ávila; Álvaro Carbayo; Ana Vesperinas-Castro; Pere Domingo; Isabel Illa; Eduard Gallardo; Elena Cortés-Vicente
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.